Skip to main content
. 2016 Apr 25;52(4):509–520. doi: 10.1007/s11262-016-1337-7

Table 3.

Percentage of sequence identities of different regions of SAIBK2 compared with other IBV strains

Strain Complete genome Gene 1
Gene 1 Nsp2 Nsp3 Nsp4 Nsp5 Nsp6 Nsp7
Beaudette 86.7 87.3 85.2 85.8 85.6 86.8 85.8 92.4
Gray 87.0 87.5 84.3 86.1 87.5 87.2 85.9 92.0
Holte 85.7 87.6 86.0 85.9 86.4 86.6 85.4 92.4
YN 90.8 91.9 92.8 93.9 92.5 85.3 86.7 94.4
Mass41_1985 86.5 87.3 84.9 86.0 85.2 87.8 84.8 92.0
4/91_vaccine 86.3 86.7 85.3 84.3 86.0 85.6 84.0 92.4
Connecticut_vaccine 87.1 87.3 84.5 85.6 86.2 86.9 85.3 92.4
Mass41_2006 87.2 87.3 84.3 85.6 86.7 86.9 85.3 92.4
California_99 86.9 87.2 85.4 85.2 87.0 86.2 85.1 92.0
Arkansas_DPI 87.1 87.4 85.3 85.1 86.8 86.9 86.1 92.0
Delaware 84.6 86.8 85.5 84.1 86.8 85.6 84.2 92.4
Georgia_1998_Vaccine 85.0 87.2 85.0 85.4 86.7 83.4 85.9 92.0
H52 86.4 87.0 85.5 84.6 86.9 85.6 84.5 92.0
H120 86.5 87.1 85.3 84.7 86.6 85.6 84.2 92.0
YX10 96.1 96.1 97.2 93.6 91.8 99.7 98.2 96.8
SAIBK 89.1 90.2 93.0 92.7 86.5 86.6 86.4 92.0
Strain Gene 1
Nsp8 Nsp9 Nsp10 Nsp11 Nsp12 Nsp13 Nsp14 Nsp15 Nsp16
Beaudette 86.5 89.5 90.8 90.9 88.7 89.6 91.6 86.7 85.8
Gray 87.8 88.9 90.1 92.4 88.8 89.4 91.2 87.8 86.6
Holte 88.3 87.4 89.4 92.4 89.6 89.6 90.3 87.3 88.6
YN 87.6 91.3 91.5 97.0 95.3 89.9 89.1 88.8 94.7
Mass41_1985 87.0 88.9 90.1 95.5 89.7 89.3 90.4 86.5 86.2
4/91_vaccine 87.1 88.6 90.1 89.4 89.2 89.3 88.8 86.2 86.7
Connecticut_vaccine 88.1 89.8 88.7 93.9 89.3 89.9 90.4 87.6 85.8
Mass41_2006 87.0 89.2 91.3 92.4 89.1 89.8 90.0 88.1 86.6
California_99 87.6 88.3 88.3 93.9 89.3 89.6 90.2 87.4 85.3
Arkansas_DPI 88.1 89.8 89.9 92.4 88.8 89.9 90.3 87.5 88.2
Delaware 87.1 88.3 91.3 89.4 89.1 88.8 89.3 87.2 86.8
Georgia_1998_Vaccine 87.8 89.8 91.3 93.9 88.9 89.5 90.5 87.6 85.9
H52 86.7 88.6 90.1 95.5 89.7 89.2 90.2 86.6 86.4
H120 87.3 89.5 91.5 89.4 89.1 89.6 90.2 88.0 86.6
YX10 94.9 97.3 98.6 95.5 97.7 98.0 99.0 97.1 93.7
SAIBK 86.7 88.9 90.8 89.4 89.4 89.9 88.8 88.7 93.1
Strain Gene 2 Gene 3 Gene 4 Gene 5 Gene 6
S1 S2 3a 3b E M 5a 5b N
Beaudette 77.4 85.4 83.3 76.9 87.9 90.1 92.9 97.6 89.1
Gray 75.3 86.6 85.6 74.9 86.1 89.2 100.0 98.0 89.5
Holte 76.1 86.0 79.9 74.4 87.9 88.2 93.4 95.2 89.0
YN 79.8 93.2 93.1 75.9 87.6 91.3 83.8 96.0 87.6
Mass41_1985 77.4 85.8 83.3 77.4 88.2 90.1 89.9 97.2 90.4
4/91_vaccine 78.1 85.1 84.5 72.3 81.2 90.6 89.9 97.2 88.5
Connecticut vaccine 76.6 86.4 82.2 73.3 86.1 90.9 100.0 100.0 90.9
Mass41_2006 77.4 86.1 82.2 73.3 85.8 91.0 100.0 99.2 90.9
California_99 75.5 85.4 82.2 73.3 88.8 91.6 100.0 98.8 89.9
Arkansas_DPI 75.6 86.4 86.2 73.8 85.8 90.7 100.0 99.6 90.7
Delaware 57.9 75.0 82.2 73.3 87.0 89.4 98.0 99.2 89.5
Georgia_1998_Vaccine 58.6 74.8 82.8 74.4 88.8 90.4 99.5 100.0 90.8
H52 77.7 85.4 82.8 77.4 87.6 90.3 93.9 96.8 88.7
H120 77.4 85.6 83.3 77.4 86.7 90.0 94.4 97.2 88.3
YX10 98.7 98.0 99.4 93.8 97.3 97.5 83.8 92.8 90.1
SAIBK 80.3 93.1 91.4 76.9 86.7 90.1 84.3 96.4 88.2

The highest nucleotide identities of different regions are indicated in bold values